Fluorescent contrast agent effective in spotting prostate cancer

06/30/2008 | HealthImaging.com

Cytate, a contrast agent, has more fluorescence in cancerous prostate tissue than in normal tissue, researchers have found while working on a project aimed at using imaging instead of biopsies to detect prostate cancer. "Cytate essentially is a smart reagent that attaches to cancerous cells. It is an excellent contrast agent because its absorption and fluorescence spectra line the near-infrared tissue optical window," said one of the researchers.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX